Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
Tatsuhiro Shibata(United Cerebral Palsy), Satoshi Yasuda(Tohoku University), Hisao Ogawa(Kumamoto University Hospital), Shoji Kawakami(National Cerebral and Cardiovascular Center), Kazuhiro Nakao(United Cerebral Palsy), Toshiyuki Nagai(Hokkaido University), Toshihisa Anzai(Hokkaido University), Tomoaki Kanaya(United Cerebral Palsy), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Masashi Fujino(National Cerebral and Cardiovascular Center), Tomotaka Tanaka(Kyoto University), Teruo Noguchi(National Cerebral and Cardiovascular Center), Yasuhide Asaumi(National Cerebral and Cardiovascular Center), Kazuyuki Nagatsuka(United Cerebral Palsy), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Yoshihiro Miyamoto(Asahikawa City Hospital), Yoichi Goto(United Cerebral Palsy), Kengo Kusano(National Cerebral and Cardiovascular Center)
Cited by 401
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753